Vicarious Surgical (RBOT) Competitors $11.29 -1.90 (-14.39%) Closing price 07/25/2025 03:59 PM EasternExtended Trading$12.69 +1.40 (+12.42%) As of 07/25/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock RBOT vs. MGRM, CV, CVRX, SGHT, TLSI, INGN, PROF, ELMD, RCEL, and LNSRShould you be buying Vicarious Surgical stock or one of its competitors? The main competitors of Vicarious Surgical include Monogram Orthopaedics (MGRM), CapsoVision (CV), CVRx (CVRX), Sight Sciences (SGHT), TriSalus Life Sciences (TLSI), Inogen (INGN), Profound Medical (PROF), Electromed (ELMD), Avita Medical (RCEL), and LENSAR (LNSR). These companies are all part of the "medical equipment" industry. Vicarious Surgical vs. Its Competitors Monogram Orthopaedics CapsoVision CVRx Sight Sciences TriSalus Life Sciences Inogen Profound Medical Electromed Avita Medical LENSAR Vicarious Surgical (NYSE:RBOT) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, dividends, earnings, analyst recommendations, profitability, media sentiment, institutional ownership and risk. Is RBOT or MGRM more profitable? Monogram Orthopaedics' return on equity of -115.71% beat Vicarious Surgical's return on equity.Company Net Margins Return on Equity Return on Assets Vicarious SurgicalN/A -120.53% -85.51% Monogram Orthopaedics N/A -115.71%-92.75% Does the media prefer RBOT or MGRM? In the previous week, Monogram Orthopaedics had 1 more articles in the media than Vicarious Surgical. MarketBeat recorded 1 mentions for Monogram Orthopaedics and 0 mentions for Vicarious Surgical. Monogram Orthopaedics' average media sentiment score of 1.87 beat Vicarious Surgical's score of 0.00 indicating that Monogram Orthopaedics is being referred to more favorably in the news media. Company Overall Sentiment Vicarious Surgical Neutral Monogram Orthopaedics Very Positive Which has more volatility and risk, RBOT or MGRM? Vicarious Surgical has a beta of 1.4, indicating that its stock price is 40% more volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.59, indicating that its stock price is 41% less volatile than the S&P 500. Do insiders & institutionals hold more shares of RBOT or MGRM? 47.3% of Vicarious Surgical shares are held by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are held by institutional investors. 12.0% of Vicarious Surgical shares are held by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth. Which has stronger earnings and valuation, RBOT or MGRM? Monogram Orthopaedics has higher revenue and earnings than Vicarious Surgical. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Vicarious Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVicarious SurgicalN/AN/A-$63.22M-$10.45-1.08Monogram Orthopaedics$370K547.89-$16.33M-$0.45-12.62 Do analysts recommend RBOT or MGRM? Vicarious Surgical presently has a consensus target price of $8.50, suggesting a potential downside of 24.73%. Monogram Orthopaedics has a consensus target price of $5.40, suggesting a potential downside of 4.93%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, analysts clearly believe Monogram Orthopaedics is more favorable than Vicarious Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vicarious Surgical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryMonogram Orthopaedics beats Vicarious Surgical on 11 of the 15 factors compared between the two stocks. Get Vicarious Surgical News Delivered to You Automatically Sign up to receive the latest news and ratings for RBOT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding RBOT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RBOT vs. The Competition Export to ExcelMetricVicarious SurgicalMED INSTRUMENTS IndustryMedical SectorNYSE ExchangeMarket Cap$78.22M$6.85B$5.70B$21.11BDividend YieldN/A1.27%4.60%3.60%P/E Ratio-1.0825.4528.1028.44Price / SalesN/A64.09429.3758.65Price / CashN/A20.5536.2222.92Price / Book1.434.758.664.69Net Income-$63.22M$176.14M$3.25B$995.51M7 Day Performance9.58%2.92%4.22%1.65%1 Month Performance46.38%3.23%10.51%4.54%1 Year Performance38.81%7.28%34.40%9.99% Vicarious Surgical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RBOTVicarious Surgical0.3741 of 5 stars$11.29-14.4%$8.50-24.7%+46.6%$78.22MN/A-1.08210Gap DownHigh Trading VolumeMGRMMonogram Orthopaedics1.0841 of 5 stars$5.87+78.4%$5.40-8.0%+126.3%$209.49MN/A-13.0428Gap UpHigh Trading VolumeCVCapsoVisionN/A$4.37-4.4%N/AN/A$202.51MN/A0.0090Negative NewsGap DownCVRXCVRx3.0268 of 5 stars$7.35+7.6%$14.50+97.3%-12.5%$191.64M$52.87M-3.37160Positive NewsSGHTSight Sciences1.408 of 5 stars$3.70+8.5%$4.10+10.8%-56.5%$191.28M$78.11M-3.78210Upcoming EarningsTLSITriSalus Life Sciences2.849 of 5 stars$4.98+1.8%$10.75+115.9%-20.1%$188.44M$32.14M-4.45106News CoveragePositive NewsINGNInogen4.2487 of 5 stars$6.71-3.0%$11.00+63.9%-29.9%$180.41M$339.96M-5.831,030PROFProfound Medical2.6593 of 5 stars$5.75-1.0%$11.50+100.0%-47.9%$172.79M$10.68M-4.71150News CoveragePositive NewsELMDElectromed1.4093 of 5 stars$19.30+1.2%$38.00+96.9%+26.9%$161.85M$61.44M25.73160News CoverageAnalyst ForecastAnalyst RevisionRCELAvita Medical1.341 of 5 stars$5.88+3.2%$16.50+180.6%-43.4%$155.41M$64.25M-2.68130Positive NewsLNSRLENSAR1.2718 of 5 stars$12.90-1.0%$15.00+16.3%+143.0%$152.09M$53.49M-2.66110Positive News Related Companies and Tools Related Companies MGRM Alternatives CV Alternatives CVRX Alternatives SGHT Alternatives TLSI Alternatives INGN Alternatives PROF Alternatives ELMD Alternatives RCEL Alternatives LNSR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:RBOT) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vicarious Surgical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vicarious Surgical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
